October 24, 2007Open Access

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Patients with squamous-cell carcinoma of the head and neck who received docetaxel plus cisplatin and fluorouracil induction chemotherapy plus chemoradiotherapy had a significantly longer survival than did patients who received cisplatin and fluorouracil induction chemotherapy plus chemoradiotherapy. (ClinicalTrials.gov number, NCT00273546 ClinicalTrials.gov.).

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Posner et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d80b4145af6083e6ae2afc — DOI: https://doi.org/10.1056/nejmoa070956

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Authors

Marshall R. Posner

Diáne Hershock

C. Blajman

Journals

New England Journal of Medicine

Actions

Institutions

University of Pittsburgh

Dana-Farber Cancer Institute

Vanderbilt University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion